IL10 and psoriasis: Based on the T- and B-cell IFN-γ and IL-10 responses to citLL37 in patients with psoriasis, we identified two distinct clusters of patients: ten high-responders (cluster 1) and nine low-responders (cluster 2) (Figure 5A).